Related Experiment Video
Updated: Aug 8, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Experimental study on the suppression of human nuclear receptor hLRH-1 via a vector-based RNA interference
Shui-Liang Wang1, Feng-Hua Lan, Ji-Liang Fu
1PLA Center for Laboratory Medicine, Fuzhou General Hospital, Fuzhou 350025, China.
Abstract:
To explore the inhibitions of human nuclear receptor hLRH-1 via RNA interference, siRNAs expressing vectors pShLRH-1.1 and pShLRH-1.2, and targeting hLRH-1 were designed and constructed. The recombinants were introduced into hepatocellular carcinoma cells, BEL-7402, mediated by lipofectamin. RT-PCR was carried out to examine the inhibition ratio of hLRH-1 expression. The same method was also applied to analyze the expression of farnesyl pyrophosphate synthetase (FPPS) gene. Our results demonstrated that after transient transfection, both pShLRH-1.1 and pShLRH-1.2 could trigger the efficient inhibition of hLRH-1 in cultured cells, BEL-7402. The inhibition ratios were up to 80%. By comparing with non-transfection and vector-transfection control, the expression of FPPS in cells with inhibition of hLRH-1 was up-regulated significantly. Thus, the inhibition of expression of hLRH-1 in cultured cells was achieved via RNA interference in this study. Our results also suggested that hLRH-1 acts as a negative regulator in FPPS expression.
Insights
RNA interference effectively inhibited human nuclear receptor LRH-1 (hLRH-1) expression in liver cancer cells, leading to significant upregulation of farnesyl pyrophosphate synthetase (FPPS). This suggests hLRH-1 negatively regulates FPPS.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The human nuclear receptor LRH-1 (hLRH-1) plays a role in cellular processes.
- Understanding hLRH-1's regulatory functions is crucial for cancer research.
Purpose of the Study:
- To investigate the inhibition of hLRH-1 expression using RNA interference.
- To explore the impact of hLRH-1 inhibition on farnesyl pyrophosphate synthetase (FPPS) gene expression.
Main Methods:
- Designed and constructed siRNAs expressing vectors (pShLRH-1.1 and pShLRH-1.2) targeting hLRH-1.
- Transfected hepatocellular carcinoma cells (BEL-7402) with siRNA vectors using lipofectamine.
- Utilized RT-PCR to quantify hLRH-1 and FPPS gene expression levels.
Main Results:
- Both pShLRH-1.1 and pShLRH-1.2 vectors achieved efficient inhibition of hLRH-1 expression, reaching up to 80% inhibition.
- Compared to control groups, FPPS gene expression was significantly upregulated in BEL-7402 cells with inhibited hLRH-1.
- RNA interference successfully inhibited hLRH-1 expression in cultured liver cancer cells.
Conclusions:
- hLRH-1 expression can be effectively inhibited in BEL-7402 cells via RNA interference.
- hLRH-1 functions as a negative regulator of FPPS expression.
- These findings provide insights into the molecular mechanisms involving hLRH-1 in hepatocellular carcinoma.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

